Skip to main content

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1164508 BOSTON, MA

Position in REGN

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$132,562,617
-$17,716,612 QoQ
Shares Held
171,571
-11.9% QoQ
Ownership
0.164%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
13 quarters on record
Voting authority Sole 73.0222473494938.ToString("F0")% Shared 0.ToString("F0")% None 26.977752650506204.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $1,767,735,657 across 48 Biotechnology names. REGN ranks #5 (7.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 REGN
Regeneron Pharmaceuticals, Inc.
This page
171,571 $132,562,617

All Filings in REGN

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $132,562,617 171,571
2025-12-31 $150,279,229 194,695
2025-09-30 $108,284,205 192,584
2025-06-30 $3,183,075 6,063
2023-09-30 $1,861,535 2,262
2023-06-30 $1,625,337 2,262
2022-12-31 $1,198,394 1,661
2022-09-30 $692,314 1,005
2022-06-30 $105,541,532 178,542
2022-03-31 $25,298,867 36,223
2021-12-31 $2,913,833 4,614
2020-12-31 $338,177 700
2020-09-30 $6,829,316 12,200